SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-075426
Filing Date
2024-03-22
Accepted
2024-03-22 17:06:39
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d795877d10ka.htm   iXBRL 10-K/A 50882
2 EX-31.1 d795877dex311.htm EX-31.1 3609
3 EX-31.2 d795877dex312.htm EX-31.2 3491
  Complete submission text file 0001193125-24-075426.txt   275841

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iobt-20231231.xsd EX-101.SCH 4602
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iobt-20231231_cal.xml EX-101.CAL 675
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iobt-20231231_def.xml EX-101.DEF 19271
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20231231_lab.xml EX-101.LAB 24293
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20231231_pre.xml EX-101.PRE 20136
21 EXTRACTED XBRL INSTANCE DOCUMENT d795877d10ka_htm.xml XML 7387
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41008 | Film No.: 24776126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)